688050.SH
爱博医疗
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 39.22
−3.11%Year over year
Reported trailing growth
- Revenue
- +4.6%
- EBITDA
- —
- EBIT
- -31.4%
- EPS
- -31.0%
- Free cash flow
- +95.8%
- Operating cash flow
- -15.4%
Forward estimates
Based on analyst estimates
- Revenue
- +36.9%
- EBITDA
- +47.9%
- EPS
- +37.6%
Three-year CAGR
- Revenue
- +36.8%
- EBITDA
- +14.4%
- EBIT
- +3.8%
- Net income
- +4.8%
- EPS
- -14.1%
- Free cash flow
- +1246.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026